S

Svas Biosana SpA
MIL:SVS

Watchlist Manager
Svas Biosana SpA
MIL:SVS
Watchlist
Price: 8.86 EUR -0.23% Market Closed
Market Cap: €47.3m

Wall Street
Price Targets

SVS Price Targets Summary
Svas Biosana SpA

Wall Street analysts forecast SVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SVS is 17.44 EUR with a low forecast of 17.27 EUR and a high forecast of 17.96 EUR.

Lowest
Price Target
17.27 EUR
95% Upside
Average
Price Target
17.44 EUR
97% Upside
Highest
Price Target
17.96 EUR
103% Upside
Svas Biosana SpA Competitors:
Price Targets
PLC
PLC SpA
28% Upside
GSBC
Great Southern Bancorp Inc
0% Upside
ROKU
Roku Inc
44% Upside
CNTA
Centessa Pharmaceuticals PLC
77% Upside
VRTX
Vertex Pharmaceuticals Inc
16% Upside
XLO
Xilio Therapeutics Inc
277% Upside

Revenue
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 5 years the compound annual growth rate for Svas Biosana SpA's revenue is 10%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

15% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
15% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 5 years the compound annual growth rate for Svas Biosana SpA's operating income is 15%. The projected CAGR for the next 3 years is 11%.

Net Income
Forecast

19% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
19% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 5 years the compound annual growth rate for Svas Biosana SpA's net income is 19%. The projected CAGR for the next 3 years is 15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SVS's stock price target?
Price Target
17.44 EUR

According to Wall Street analysts, the average 1-year price target for SVS is 17.44 EUR with a low forecast of 17.27 EUR and a high forecast of 17.96 EUR.

What is Svas Biosana SpA's Revenue forecast?
Projected CAGR
10%

For the last 5 years the compound annual growth rate for Svas Biosana SpA's revenue is 10%. The projected CAGR for the next 3 years is 10%.

What is Svas Biosana SpA's Operating Income forecast?
Projected CAGR
11%

For the last 5 years the compound annual growth rate for Svas Biosana SpA's operating income is 15%. The projected CAGR for the next 3 years is 11%.

What is Svas Biosana SpA's Net Income forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Svas Biosana SpA's net income is 19%. The projected CAGR for the next 3 years is 15%.

Back to Top